Skip to main content
. Author manuscript; available in PMC: 2010 Mar 29.
Published in final edited form as: Genet Med. 2007 Apr;9(4):219–227. doi: 10.1097/GIM.0b013e3180423cca

Table 4.

GORs for heterozygotes and homozygotes for two-, three-, and four-SNP haplotypes consisting of SNPs increasing risk in 146 Taiwanese CL/P case-parent trios

Diplotype Na (%) GOR (95% CI) Diplotype Na (%) GOR (95% CI)
rs599021-rs2235373 (P = 1 × 10−4)b n = 556 rs2235373-rs2235371 (P < 10−4) n = 548
AA/AA 140 (25.2) Reference AT/AT 100 (18.3) Reference
AA/AG 153 (27.5) 1.35 (0.69–2.66) AT/AC 31 (5.7) 0.18 (0.04–0.90)
AA/CG 103 (18.5) 1.62 (0.75–3.50) AT/GC 221 (40.3) 0.85 (0.44–1.66)
AG/AG 61 (11.0) 5.10 (2.08–12.48) AC/GC 31 (5.7) 1.47 (0.52–4.16)
AG/CG 68 (12.2) 5.95 (2.53–13.99) GC/ GC 152 (27.7) 3.51 (1.66–7.42)
CG/CG 25 (4.5) 3.96 (1.40–11.24) 4 types (<4%) 13 (2.4) 0.61 (0.05–7.01)
3 types (<4%) 6 (3.3) 1.91 (0.15–24.12)
rs599021-rs2235371 (P = 2 × 10−4) n = 548 rs2235373-rs2013162 (P = 1 × 10−4) n = 548
AT/AT 101 (18.4) Reference AA/AA 137 (25.0) Reference
AT/AC 164 (29.9) 0.70 (034–1.43) AA/GA 39 (7.1) 1.64 (0.60–4.52)
AT/CC 91 (16.6) 0.97 (0.43–2.19) AA/GC 212 (38.7) 1.34 (0.73–2.47)
AC/AC 81 (14.8) 2.29 (1.01–5.20) GA/GC 41 (7.5) 3.94 (1.48–10.46)
AC/CC 82 (15.0) 3.27 (1.46–7.31) GC/ GC 103 (18.8) 5.01 (2.35–10.66)
CC/CC 25 (4.6) 3.05 (1.08–8.63) 4 types (<4%) 16 (2.9) 1.26 (0.18–8.61)
3 types (<4%) 4 (0.7) 2.04 (0.11–36.83)
rs599021-rs2013162 (P = 3.7 × 10−3) n = 548 rs2235371-rs2013162 (P < 10−4) n = 544
AA/AA 182 (33.2) Reference TA/TA 98 (18.0) Reference
AA/AC 135 (24.6) 1.14 (0.63–2.08) TA/CA 68 (12.5) 0.57 (0.23–1.38)
AA/CC 121 (22.1) 1.44 (0.74–2.79) TA/CC 182 (33.5) 0.78 (0.40–1.55)
AC/AC 29 (5.3) 3.71 (1.27–10.85) CA/CC 68 (12.5) 2.17 (0.95–5.00)
AC/CC 50 (9.1) 4.84 (2.05–11.44) CC/CC 102 (18.8) 3.62 (1.64–7.97)
CC/CC 25 (4.6) 3.16 (1.18–8.47) 4 types (<4%) 26 (4.8) 0.37 (0.08–1.79)
3 types (<4%) 6 (1.1) 1.45 (0.11–18.71)
rs599021-rs2235373-rs2235371 (P < 10−4) n = 548 rs599021-rs2235371-rs2013162 (P = 1 × 10−4) n = 544
AAT/AAT 99 (18.1) Reference ATA/ATA 97 (17.8) Reference
AAT/AAC 31 (5.7) 0.19 (0.04–0.93) ATA/ACA 68 (12.5) 0.57 (0.23–1.40)
AAT/AGC 128 (23.4) 0.79 (0.36–1.72) ATA/ACC 89 (16.4) 0.61 (0.26–1.42)
AAT/CGC 90 (16.4) 0.88 (0.38–2.03) ATA/CCC 90 (16.5) 0.95 (0.41–2.19)
AGC/AGC 59 (10.8) 3.98 (1.56–10.14) ACA/ACC 37 (6.8) 2.13 (0.79–5.72)
AGC/CGC 68 (12.4) 4.14 (1.72–9.96) ACA/CCC 31 (5.7) 2.34 (0.84–6.53)
CGC/CGC 25 (4.6) 2.56 (0.90–7.29) ACC/ACC 27 (5.0) 4.12 (1.26–13.51)
11 types (<4%) 48 (8.8) 1.48 (0.54–4.07) ACC/CCC 50 (9.2) 4.59 (1.76–11.97)
CCC/CCC 25 (4.6) 2.80 (0.97–8.05)
8 types (<4%) 30 (5.5) 0.53 (0.12–2.30)
rs599021-rs2235373-rs2013162 (P = 5 × 10−4) n = 548 rs2235373-rs2235371-rs2013162 (P < 10−4) n = 548
AAA/AAA 135 (24.6) Reference ATA/ATA 98 (18.0) Reference
AAA/AGA 39 (7.1) 1.72 (0.63–4.70) ATA/ACA 31 (5.7) 0.17 (0.04–0.84)
AAA/AGC 105 (19.2) 1.15 (0.55–2.39) ATA/GCA 36 (6.6) 1.15 (0.41–3.25)
AAA/CGC 103 (18.8) 1.57 (0.73–3.41) ATA/GCC 181 (33.3) 0.79 (0.39–1.56)
AGA/AGC 23 (4.2) 5.18 (1.61–16.67) ACA/GCC 26 (4.8) 2.03 (0.68–6.02)
AGC/AGC 28 (5.1) 5.76 (1.83–18.16) GCA/GCC 41 (7.5) 2.65 (0.98–7.19)
AGC/CGC 50 (9.1) 6.99 (2.70–18.06) GCC/GCC 102 (18.8) 3.71 (1.67–8.23)
CGC/CGC 25 (4.6) 3.70 (1.31–10.46) 12 types (<4%) 29 (5.3) 0.40 (0.07–2.15)
8 types (<4%) 40 (7.3) 2.57 (0.83–7.97)
rs599021-rs2235373-rs2235371-rs2013162 (P < 10−4) n = 544
AATA/AATA 97 (17.8) Reference AGCA/AGCC 23 (4.2) 3.55 (1.09–11.59)
AATA/AACA 31 (5.7) 0.19 (0.04–0.93) AGCC/AGCC 27 (5.0) 4.58 (1.39–15.09)
AATA/AGCA 36 (6.6) 1.31 (0.46–3.72) AGCC/CGCC 50 (9.2) 4.90 (1.85–12.97)
AATA/AGCC 88 (16.2) 0.63 (0.26–1.50) CGCC/CGCC 25 (4.6) 2.53 (0.89–7.20)
AATA/CGCC 90 (16.5) 0.91 (0.39–2.10) 20 types (<4%) 77 (14.2) 1.68 (0.07–2.15)
a

N and n refer to the number of subjects carrying the genotype (including both cases and pseudosibs) and the number of case/pseudocontrol sets.

b

Global P value for the conditional logistic model.

GORs, genotypic odds ratios; SNP, single nucleotide polymorphism; CL/P, cleft lip with or without cleft palate.